Sun Pharmaceutical Industries Ltd. | SUNPHARMA | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
![]() | 151,408 | 99,294 | 72,756 | 64,876 | 64,455 |
Short-term investment |
![]() | 2,309 | 40,906 | 39,507 | 48,974 | 31,301 |
Accounts receivables |
![]() | 72,026 | 78,153 | 88,842 | 94,212 | 90,614 |
Inventories |
![]() | 68,328 | 68,807 | 78,860 | 78,750 | 89,970 |
Deferred income taxes |
![]() | 0 | 0 | 0 | 0 | 0 |
Other current assets |
![]() | 35,465 | 29,199 | 30,727 | 29,730 | 28,081 |
Total current assets |
![]() | 329,537 | 316,359 | 310,692 | 316,542 | 304,421 |
Gross property plant... |
![]() | 84,953 | 91,590 | 100,274 | 105,674 | 102,350 |
Accumulated Depriciat... |
![]() | 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
![]() | 84,953 | 91,590 | 100,274 | 105,674 | 102,350 |
Work in Progress |
![]() | 15,648 | 14,345 | 9,108 | 6,589 | 9,365 |
Miscellaneous Investment |
![]() | 10,308 | 53,996 | 40,476 | 53,514 | 65,789 |
Deferred income taxes |
![]() | 56,178 | 53,834 | 58,210 | 65,595 | 69,892 |
Intangible assets |
![]() | 48,803 | 51,176 | 63,537 | 63,595 | 56,607 |
Goodwill |
![]() | 55,362 | 56,067 | 59,558 | 64,815 | 62,876 |
Other long-term assets |
![]() | 13,314 | 5,660 | 5,084 | 6,201 | 5,367 |
Total non-current assets |
![]() | 284,566 | 326,669 | 336,246 | 365,983 | 372,247 |
Total assets |
![]() | 614,102 | 643,028 | 646,938 | 682,525 | 676,667 |
Short-term debt |
![]() | 66,549 | 79,797 | 83,708 | 55,494 | 24,449 |
Accounts Payable... |
![]() | 43,954 | 47,662 | 41,479 | 40,937 | 39,737 |
Provisions |
![]() | 40,159 | 51,097 | 29,323 | 39,702 | 45,827 |
Taxes Payable |
![]() | 1,471 | 1,328 | 1,269 | 2,020 | 1,791 |
Deferred Revenues |
![]() | 0 | 0 | 0 | 0 | 0 |
Capital Leases |
![]() | 0 | 0 | 0 | 0 | 0 |
Other current liabilities |
![]() | 26,737 | 18,759 | 17,617 | 18,911 | 49,653 |
Total current liabilities |
![]() | 178,870 | 198,643 | 173,396 | 157,064 | 161,456 |
Long-term debt |
![]() | 14,361 | 17,721 | 15,226 | 20,289 | 8,981 |
Investments Liabilities |
![]() | 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
![]() | 3,148 | 2,190 | 1,043 | 581 | 445 |
Provisions |
![]() | 12,111 | 4,045 | 4,304 | 5,110 | 3,271 |
Capital Leases |
![]() | 0 | 0 | 0 | 0 | 0 |
Other longterm liabilities |
![]() | 1,307 | 583 | 5,743 | 8,233 | 7,715 |
Total non-current liabilities |
![]() | 30,927 | 24,538 | 26,316 | 34,213 | 20,413 |
Total liabilities |
![]() | 209,797 | 223,181 | 199,712 | 191,278 | 181,869 |
Share Capital |
![]() | 2,399 | 2,399 | 2,399 | 2,399 | 2,399 |
Share premium |
![]() | 0 | 0 | 0 | 0 | 0 |
Retained earnings |
![]() | 363,997 | 378,606 | 411,691 | 450,245 | 462,229 |
Accumulated other equity |
![]() | 0 | 0 | 0 | 0 | 0 |
Preferred Stock |
![]() | 0 | 0 | 0 | 0 | 0 |
Minority Interest |
![]() | 37,909 | 38,842 | 33,135 | 38,602 | 30,171 |
Total Equity |
![]() | 404,305 | 419,847 | 447,226 | 491,247 | 494,798 |
Total Liabilities and Equity |
![]() | 614,102 | 643,028 | 646,938 | 682,525 | 676,667 |
Cash per Share |
![]() | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
![]() | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |